Rapid Antidepressant Action and Restoration of Excitatory Synaptic Strength After Chronic Stress by Negative Modulators of Alpha5-Containing GABAA Receptors
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rapid Antidepressant Action and Restoration of Excitatory Synaptic Strength After Chronic Stress by Negative Modulators of Alpha5-Containing GABAA Receptors
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume 40, Issue 11, Pages 2499-2509
Publisher
Springer Nature
Online
2015-04-22
DOI
10.1038/npp.2015.112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics
- (2015) Chadi G. Abdallah et al. Annual Review of Medicine
- An excitatory synapse hypothesis of depression
- (2015) Scott M. Thompson et al. TRENDS IN NEUROSCIENCES
- Restoring Mood Balance in Depression: Ketamine Reverses Deficit in Dopamine-Dependent Synaptic Plasticity
- (2014) Pauline Belujon et al. BIOLOGICAL PSYCHIATRY
- NEUROBIOLOGY OF STRESS, DEPRESSION, AND RAPID ACTING ANTIDEPRESSANTS: REMODELING SYNAPTIC CONNECTIONS
- (2014) Ronald S. Duman DEPRESSION AND ANXIETY
- What Did STAR*D Teach Us? Results From a Large-Scale, Practical, Clinical Trial for Patients With Depression
- (2014) Bradley N. Gaynes et al. PSYCHIATRIC SERVICES
- Synaptic Mechanisms Underlying Rapid Antidepressant Action of Ketamine
- (2013) Ege T. Kavalali et al. AMERICAN JOURNAL OF PSYCHIATRY
- Scopolamine Rapidly Increases Mammalian Target of Rapamycin Complex 1 Signaling, Synaptogenesis, and Antidepressant Behavioral Responses
- (2013) Bhavya Voleti et al. BIOLOGICAL PSYCHIATRY
- Activation of Mammalian Target of Rapamycin and Synaptogenesis: Role in the Actions of Rapid-Acting Antidepressants
- (2013) Jason M. Dwyer et al. BIOLOGICAL PSYCHIATRY
- Chronic Stress Induces a Selective Decrease in AMPA Receptor-Mediated Synaptic Excitation at Hippocampal Temporoammonic-CA1 Synapses
- (2013) A. J. Kallarackal et al. JOURNAL OF NEUROSCIENCE
- Local potentiation of excitatory synapses by serotonin and its alteration in rodent models of depression
- (2013) Xiang Cai et al. NATURE NEUROSCIENCE
- The Impact of NMDA Receptor Blockade on Human Working Memory-Related Prefrontal Function and Connectivity
- (2013) Naomi R Driesen et al. NEUROPSYCHOPHARMACOLOGY
- Synaptic Potentiation Is Critical for Rapid Antidepressant Response to Ketamine in Treatment-Resistant Major Depression
- (2012) Brian R. Cornwell et al. BIOLOGICAL PSYCHIATRY
- Anhedonia requires MC4R-mediated synaptic adaptations in nucleus accumbens
- (2012) Byung Kook Lim et al. NATURE
- Repeated Stress Causes Cognitive Impairment by Suppressing Glutamate Receptor Expression and Function in Prefrontal Cortex
- (2012) Eunice Y. Yuen et al. NEURON
- Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents
- (2012) Ronald S. Duman et al. TRENDS IN NEUROSCIENCES
- Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
- (2011) Nanxin Li et al. BIOLOGICAL PSYCHIATRY
- Comparison of the effects of acute and chronic administration of ketamine on hippocampal oscillations: relevance for the NMDA receptor hypofunction model of schizophrenia
- (2011) Kara Kittelberger et al. Brain Structure & Function
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- Differential effects produced by ketamine on oscillatory activity recorded in the rat hippocampus, dorsal striatum and nucleus accumbens
- (2010) Mark J Hunt et al. JOURNAL OF PSYCHOPHARMACOLOGY
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- Etomidate Targets α5 γ-Aminobutyric Acid Subtype A Receptors to Regulate Synaptic Plasticity and Memory Blockade
- (2009) Loren J. Martin et al. ANESTHESIOLOGY
- In Vitro and in Vivo Properties of 3-tert-Butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA Receptor 5 Subtype-Selective Inverse Agonist
- (2009) J. R. Atack et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Ketamine and the next generation of antidepressants with a rapid onset of action
- (2009) Rodrigo Machado-Vieira et al. PHARMACOLOGY & THERAPEUTICS
- GABAA Receptor α5 Subunits Contribute to GABAA,slow Synaptic Inhibition in Mouse Hippocampus
- (2008) Ewa D. Zarnowska et al. JOURNAL OF NEUROPHYSIOLOGY
- NMDA receptor-dependent switching between different gamma rhythm-generating microcircuits in entorhinal cortex
- (2008) S. Middleton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RO4938581, a novel cognitive enhancer acting at GABAA α5 subunit-containing receptors
- (2008) Theresa M. Ballard et al. PSYCHOPHARMACOLOGY
- Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors
- (2007) Sungho Maeng et al. BIOLOGICAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now